A Clinical Trial of Flonoltinib Maleate Tablets in the Treatment of JAK Inhibitor Refractory/Relapsed/Intolerant Patients With Medium to High Risk Myelofibrosis

NCT07443306 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

MF

Interventions

DRUG: Flonoltinib Maleate

Sponsor

Chengdu Zenitar Biomedical Technology Co., Ltd